OPG/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key?
- 4 December 2004
- journal article
- case report
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 24 (3), 296-300
- https://doi.org/10.1007/s10067-004-1031-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Clinical images: Hepatitis C–associated osteosclerosisArthritis & Rheumatism, 2003
- Hyperparathyroidism and Increased Serum IGF-Binding Protein-2 Levels in Hepatitis C-Associated OsteosclerosisJournal of Clinical Endocrinology & Metabolism, 1999
- Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.JCI Insight, 1998
- Hepatitis C-Associated Osteosclerosis: Late Onset after Blood Transfusion in an Elderly WomanJournal of Clinical Endocrinology & Metabolism, 1998
- Acquired osteosclerosis associated with intravenous drug use and hepatitis C infectionBone, 1996
- Paget's disease of bone possible viral basisTrends in Endocrinology & Metabolism, 1996
- Doubling skeletal mass during adult life: The syndrome of diffuse osteosclerosis after intravenous drug abuseJournal of Bone and Mineral Research, 1996
- The replyAmerican Journal Of Medicine, 1993
- Anabolic actions of parathyroid hormone on bone [published erratum appears in Endocr Rev 1994 Apr;15(2):261]Endocrine Reviews, 1993
- Case report: Idiopathic acquired diffuse osteosclerosis in a young womanJournal of Bone and Mineral Research, 1990